We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TENB icon
276
Tenable Holdings
TENB
$4.01B
$7.66M 0.05%
268,378
+94,588
+54% +$2.8M
CNQ icon
277
Canadian Natural Resources
CNQ
$94.9B
$7.65M 0.05%
577,913
+424,559
+277% +$5.83M
SKT icon
278
Tanger
SKT
$4.52B
$7.61M 0.05%
469,621
+4,806
+1% +$86.6K
CUK
279
DELISTED
Carnival PLC
CUK
$7.58M 0.05%
167,486
+43,781
+35% +$2.25M
AIR icon
280
AAR Corp
AIR
$5.76B
$7.54M 0.05%
205,064
+116,961
+133% +$3.87M
GEF icon
281
Greif
GEF
$5.04B
$7.54M 0.05%
231,791
+148,645
+179% +$5.53M
NVS icon
282
Novartis
NVS
$297B
$7.5M 0.05%
82,151
+75,231
+1,087% +$6.37M
LYFT icon
283
Lyft
LYFT
$6.63B
$7.49M 0.05%
114,044
-29,656
-21% -$1.78M
CCK icon
284
Crown Holdings
CCK
$13.1B
$7.44M 0.05%
121,792
+22,054
+22% +$1.29M
TRIP icon
285
TripAdvisor
TRIP
$1.26B
$7.44M 0.05%
+160,635
New +$7.83M
TXRH icon
286
Texas Roadhouse
TXRH
$13.7B
$7.4M 0.05%
137,801
+122,191
+783% +$6.87M
DRI icon
287
Darden Restaurants
DRI
$24.4B
$7.21M 0.04%
59,242
-29,011
-33% -$3.45M
VIAB
288
DELISTED
Viacom Inc. Class B
VIAB
$7.2M 0.04%
241,044
-216,544
-47% -$6.33M
GD icon
289
General Dynamics
GD
$106B
$7.08M 0.04%
+38,969
New +$6.71M
PII icon
290
Polaris
PII
$4.07B
$7.04M 0.04%
77,131
+76,131
+7,613% +$6.93M
TEF
291
DELISTED
Telefonica
TEF
$7.03M 0.04%
+1,049,616
New +$6.98M
DINO icon
292
HF Sinclair
DINO
$14.5B
$6.96M 0.04%
150,368
+114,340
+317% +$5.11M
CLB icon
293
Core Laboratories
CLB
$521M
$6.95M 0.04%
133,005
+132,102
+14,629% +$7.75M
GRFS
294
Grifois
GRFS
$5.4B
$6.94M 0.04%
328,954
+275,293
+513% +$5.25M
CRH icon
295
CRH
CRH
$66.8B
$6.93M 0.04%
211,660
+211,460
+105,730% +$6.88M
WTFC icon
296
Wintrust Financial
WTFC
$10.7B
$6.88M 0.04%
94,011
-554
-0.6% -$40.5K
TRP icon
297
TC Energy
TRP
$65.9B
$6.83M 0.04%
137,489
+109,289
+388% +$5.24M
UAL icon
298
United Airlines
UAL
$42.1B
$6.76M 0.04%
77,251
+66,709
+633% +$5.65M
DLTH icon
299
Duluth Holdings
DLTH
$159M
$6.75M 0.04%
+496,784
New +$8.04M
BHP icon
300
BHP
BHP
$230B
$6.73M 0.04%
129,761
-179,446
-58% -$8.67M
10 11
12
13 14

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.